abiraterone acetate
abiraterone acetate is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including ABIRATERONE ACETATE, abiraterone acetate, YONSA. Available dosage forms: tablet, tablet, film coated.
Drug Details
- Generic Name
- abiraterone acetate
- Brand Names
- ABIRATERONE ACETATE, abiraterone acetate, YONSA, Abiraterone Acetate, Zytiga
- Application Number
- NDA210308
- Sponsor
- Golden State Medical Supply, Inc.
- NDC Codes
- 13
- Dosage Forms
- TABLET, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ABIRATERONE ACETATE
Indications and Usage
1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with • Metastatic castration-resistant prostate cancer (CRPC) • Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablets are a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with • metastatic castration-resistant prostate cancer (CRPC). ( 1 ) • metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 )